بوپرنورفین+نالوکسون

Buprenorphine+Naloxone
Buprenorphine+Naloxone
نام های تجاری خارجی

US: Bunavail; Suboxone; Zubsolv

Canada: Suboxone

دسته دارویی

Analgesic, Opioid; Analgesic, Opioid Partial Agonist

ضد درد، اپیوییدی

ضد درد، آگونیست نسبی اپیویید

بارداری راهنمای طبقه بندی دارو ها در بارداری
شیردهی

Buprenorphine and its active metabolite, norbuprenorphine, are present in breast milk. It is not known if naloxone is present in breast milk; however, systemic absorption following oral administration is low (Smith 2012) and any exposure of naloxone to a breastfed infant would therefore be limited.

In general, breastfeeding is not recommended by the manufacturers of buprenorphine-containing products; the manufacturers of Zubsolv, Suboxone, and Bunavail recommend that caution be exercised when administering this specific combination product to breastfeeding women. According to the manufacturer, the decision to continue or discontinue breastfeeding during therapy should take into account the risk of infant exposure, the benefits of breastfeeding to the infant, and benefits of treatment to the mother. See individual agents.

تولیدی فاران شیمی تویسرکان
  • بوپرنورفین/نالوکسان قرص زیرزبانی 2 mg/0.5 mg (قرص بوپرنورفین / نالوکسون)
  • دارودرمان پارس
  • بوپرنورفین/نالوکسان قرص زیرزبانی 8 mg/2 mg (قرص بوپرنورفین / نالوکسون)